Ciprofloxacin-induced toxic optic neuropathy

Clinical and Experimental Ophthalmology

Volumn 35, Issue 1, 2007, Pages 102-104

  Samarakoon, Nadeeka ^a   Harrisberg, Brian ^a   Ell, Jonathan ^a  

^a Central Sydney Eye Surgeons   (Australia)

Author keywords

Ciprofloxacin; Toxic optic neuropathy

Indexed keywords

CIPROFLOXACIN;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CHRONIC DRUG ADMINISTRATION; CHRONIC OSTEOMYELITIS; COLOR VISION DEFECT; DISEASE DURATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; MALE; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; CHRONIC DISEASE; CIPROFLOXACIN; HUMANS; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; OSTEOMYELITIS; PERIMETRY; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 33846683066     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01427.x     Document Type: Article

References (4)

1. Kesler A, Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep 2003; 3: 410-14.
2. Savage D, Ogundipe A, Allen RH, Stabler S, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 2000; 319: 343-52.
3. Drugdex Drug Evaluations - Ciprofloxacin. Micromedex healthcare series. Available from: http://micromedex.hsis.uci.edu
4. Vrabec TR, Sergott RC, Jaeger EA, Savino PJ, Bosley TM. Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (Cipro). Ophthalmology 1990; 97: 707-10.